Fractyl Health Common Net Income
| GUTS Stock | 0.39 0.03 7.14% |
As of the 18th of February 2026, Fractyl Health shows the Standard Deviation of 10.31, mean deviation of 5.28, and Coefficient Of Variation of (1,469). Fractyl Health Common technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Fractyl Health Common risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and kurtosis to decide if Fractyl Health Common is priced favorably, providing market reflects its regular price of 0.39 per share. As Fractyl Health Common appears to be a penny stock we also advise to verify its jensen alpha numbers.
Fractyl Health Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 16.2 K | Revenue | Earnings Share (2.32) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -61.8 M | -64.9 M | |
| Net Loss | -61.8 M | -64.9 M | |
| Net Loss | (1.81) | (1.91) |
Fractyl | Net Income | Build AI portfolio with Fractyl Stock |
The evolution of Net Income for Fractyl Health Common provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Fractyl Health compares to historical norms and industry peers.
Latest Fractyl Health's Net Income Growth Pattern
Below is the plot of the Net Income of Fractyl Health Common over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Fractyl Health Common financial statement analysis. It represents the amount of money remaining after all of Fractyl Health Common operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Fractyl Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fractyl Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (68.69 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Fractyl Net Income Regression Statistics
| Arithmetic Mean | (43,071,496) | |
| Coefficient Of Variation | (40.59) | |
| Mean Deviation | 15,205,112 | |
| Median | (30,592,000) | |
| Standard Deviation | 17,481,476 | |
| Sample Variance | 305.6T | |
| Range | 46.6M | |
| R-Value | (0.82) | |
| Mean Square Error | 105.3T | |
| R-Squared | 0.68 | |
| Significance | 0.00005 | |
| Slope | (2,848,269) | |
| Total Sum of Squares | 4889.6T |
Fractyl Net Income History
Other Fundumenentals of Fractyl Health Common
Fractyl Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Fractyl Health is extremely important. It helps to project a fair market value of Fractyl Stock properly, considering its historical fundamentals such as Net Income. Since Fractyl Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Fractyl Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Fractyl Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will Fractyl introduce new products? Factors like these will boost the valuation of Fractyl Health. Market participants price Fractyl higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Fractyl Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Fractyl Health Common is measured differently than its book value, which is the value of Fractyl that is recorded on the company's balance sheet. Investors also form their own opinion of Fractyl Health's value that differs from its market value or its book value, called intrinsic value, which is Fractyl Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Fractyl Health's market value can be influenced by many factors that don't directly affect Fractyl Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fractyl Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fractyl Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Fractyl Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Fractyl Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fractyl Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fractyl Health.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Fractyl Health on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Fractyl Health Common or generate 0.0% return on investment in Fractyl Health over 90 days. Fractyl Health is related to or competes with Alx Oncology, Precision BioSciences, Artiva Biotherapeutics, Sutro Biopharma, Quince Therapeutics, Metagenomi Common, and ATyr Pharma. Fractyl Health is entity of United States More
Fractyl Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fractyl Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fractyl Health Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 85.71 | |||
| Value At Risk | (8.44) | |||
| Potential Upside | 11.89 |
Fractyl Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fractyl Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fractyl Health's standard deviation. In reality, there are many statistical measures that can use Fractyl Health historical prices to predict the future Fractyl Health's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.75) | |||
| Total Risk Alpha | (1.27) | |||
| Treynor Ratio | (0.92) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fractyl Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Fractyl Health February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.91) | |||
| Mean Deviation | 5.28 | |||
| Coefficient Of Variation | (1,469) | |||
| Standard Deviation | 10.31 | |||
| Variance | 106.33 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.75) | |||
| Total Risk Alpha | (1.27) | |||
| Treynor Ratio | (0.92) | |||
| Maximum Drawdown | 85.71 | |||
| Value At Risk | (8.44) | |||
| Potential Upside | 11.89 | |||
| Skewness | (4.30) | |||
| Kurtosis | 27.76 |
Fractyl Health Common Backtested Returns
Fractyl Health Common secures Sharpe Ratio (or Efficiency) of -0.1, which denotes the company had a -0.1 % return per unit of standard deviation over the last 3 months. Fractyl Health Common exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Fractyl Health's Standard Deviation of 10.31, mean deviation of 5.28, and Coefficient Of Variation of (1,469) to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.78, which means possible diversification benefits within a given portfolio. As returns on the market increase, Fractyl Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Fractyl Health is expected to be smaller as well. At this point, Fractyl Health Common has a negative expected return of -1.09%. Please make sure to confirm Fractyl Health's jensen alpha, as well as the relationship between the kurtosis and price action indicator , to decide if Fractyl Health Common performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.55 |
Good reverse predictability
Fractyl Health Common has good reverse predictability. Overlapping area represents the amount of predictability between Fractyl Health time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fractyl Health Common price movement. The serial correlation of -0.55 indicates that about 55.0% of current Fractyl Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.55 | |
| Spearman Rank Test | -0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 0.61 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Fractyl Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Fractyl Health Common reported net income of (68.69 Million). This is 120.13% lower than that of the Health Care Equipment & Supplies sector and 198.07% lower than that of the Health Care industry. The net income for all United States stocks is 112.03% higher than that of the company.
Fractyl Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fractyl Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fractyl Health could also be used in its relative valuation, which is a method of valuing Fractyl Health by comparing valuation metrics of similar companies.Fractyl Health is currently under evaluation in net income category among its peers.
Fractyl Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Fractyl Health from analyzing Fractyl Health's financial statements. These drivers represent accounts that assess Fractyl Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Fractyl Health's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Enterprise Value | 820.6M | 869.3M | 951.9M | 84.7M | 97.4M | 92.6M |
Fractyl Fundamentals
| Return On Equity | -5.18 | ||||
| Return On Asset | -0.51 | ||||
| Current Valuation | 48.7 M | ||||
| Shares Outstanding | 153.37 M | ||||
| Shares Owned By Insiders | 1.36 % | ||||
| Shares Owned By Institutions | 71.41 % | ||||
| Number Of Shares Shorted | 14.9 M | ||||
| Price To Book | 1.86 X | ||||
| Price To Sales | 21,390 X | ||||
| Revenue | 93 K | ||||
| Gross Profit | 3 K | ||||
| EBITDA | (92.85 M) | ||||
| Net Income | (68.69 M) | ||||
| Total Debt | 62.5 M | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (65.52 M) | ||||
| Short Ratio | 1.65 X | ||||
| Earnings Per Share | (2.32) X | ||||
| Target Price | 5.24 | ||||
| Number Of Employees | 101 | ||||
| Beta | 1.63 | ||||
| Market Capitalization | 64.17 M | ||||
| Total Asset | 108.08 M | ||||
| Retained Earnings | (415.31 M) | ||||
| Working Capital | 51.99 M | ||||
| Net Asset | 108.08 M |
About Fractyl Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fractyl Health Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fractyl Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fractyl Health Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fractyl Stock Analysis
When running Fractyl Health's price analysis, check to measure Fractyl Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fractyl Health is operating at the current time. Most of Fractyl Health's value examination focuses on studying past and present price action to predict the probability of Fractyl Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fractyl Health's price. Additionally, you may evaluate how the addition of Fractyl Health to your portfolios can decrease your overall portfolio volatility.